SCHEMBL11039342

SCHEMBL11039342

CSc1cccc2cc(N)ccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.53
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 3/20 0.43
CYP3A4 P08684 3/20 0.43
CASP1 P29466 3/20 0.42
ALOX15 P16050 1/20 0.42
CASP7 P55210 1/20 0.42
HBB P68871 1/20 0.42
HIF1A Q16665 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.40
KDM4E B2RXH2 3/20 0.36
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
CASP6 P55212 1/20 0.36
TP53 P04637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL224693 0.84 PLAU (0.57) PLAUALDH1A1HSD17B10CYP3A4CASP1
SCHEMBL25410815 0.80 NQO2 (0.38) ALDH1A1HSD17B10KDM4EMAPTSMN1; SMN2
SCHEMBL27659879 0.78 PLAU (0.59) PLAUALDH1A1HSD17B10CYP3A4CASP1
SCHEMBL31323067 0.74 ALDH1A1 (0.48) ALDH1A1HSD17B10CYP3A4HIF1ATDP1
SCHEMBL31038169 0.74 ALDH1A1 (0.48) ALDH1A1HSD17B10CYP3A4HIF1ATDP1
SCHEMBL385875 0.74 ALDH1A1 (0.48) ALDH1A1HSD17B10CYP3A4HIF1ATDP1
SCHEMBL11258825 0.74 IFNAR1 (0.35) ALDH1A1MAPTSMN1; SMN2LMNATSHR
SCHEMBL8035199 0.74 CYP1A2 (0.52) ALDH1A1MAPTPOLBCYP1A2CYP2A6
SCHEMBL3698024 0.74 ALDH1A1 (0.41) ALDH1A1HSD17B10HIF1ATDP1KDM4E
SCHEMBL14100536 0.74 CYP1A2 (0.63) PLAUALDH1A1HSD17B10CYP3A4CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0052932-B1 2-AMINOTETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS HAVING CENTRAL ALPHA1 AGONIST ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1984-02-22 EP disclosed
EP-0052932-A1 2-Aminotetralin compounds and pharmaceutical compositions having central alpha1 agonist activity SMITHKLINE BECKMAN CORPORATION (US) 1982-06-02 EP disclosed
US-4320148-A ANTIDEPRESSANTS SMITHKLINE CORPORATION (US) 1982-03-16 US disclosed